Li F, Freed D, Heidecker G, Galli J, et al. A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments. Vaccine 2022 May 13. pii: S0264-410X(22)00569.
PMID: 35577627